Publication: Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
Date
Date
Date
Citations
Sandborn, W. J., Cyrille, M., Hansen, M. B., Feagan, B. G., Loftus, E. V., Rogler, G., Vermeire, S., Cruz, M. L., Yang, J., Boedigheimer, M. J., Abuqayyas, L., Evangelista, C. M., Sullivan, B. A., & Reinisch, W. (2019). Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis. Gastroenterology, 156, 946-957.e18. https://doi.org/10.1053/j.gastro.2018.11.035
Abstract
Abstract
Abstract
BACKGROUND & AIMS: The α4β7 integrin is a validated target in inflammatory bowel disease. This randomized, phase 2b, placebo-controlled, double-blind study evaluated the efficacy and safety of the anti-α4β7 antibody abrilumab in patients with moderate-to-severe ulcerative colitis despite treatment with conventional therapies. METHODS: Patients (total Mayo Score 6-12, recto-sigmoidoscopy score ≥2) with inadequate response or intolerance to conventional therapies were randomized to receive subcutaneous abrilumab (7, 21, or 70 mg) on day
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Sandborn, W. J., Cyrille, M., Hansen, M. B., Feagan, B. G., Loftus, E. V., Rogler, G., Vermeire, S., Cruz, M. L., Yang, J., Boedigheimer, M. J., Abuqayyas, L., Evangelista, C. M., Sullivan, B. A., & Reinisch, W. (2019). Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis. Gastroenterology, 156, 946-957.e18. https://doi.org/10.1053/j.gastro.2018.11.035